Wellington Management Group
SIOX

Wellington Management Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Wellington Management Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,405
Closed -$206K – 2344
2018
Q1 		$206K Hold
19,405
– – ﹤0.01% 2156
2017
Q4 		$818K Buy
+19,405
New +$871K ﹤0.01% 1943

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group's SIOX Position: Q2 2018 in Review

Wellington Management Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 19,405 shares — an estimated $206K sold.

Wellington Management Group first reported a position in SIOX in Q4 2017 and held it in 2 quarters. The position peaked at $818K in Q4 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

  • Wellington Management Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Wellington Management Group sold 19,405 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $206K.
  • Wellington Management Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Wellington Management Group's Sio Gene Therapies Inc. Common Stock position peaked at $818K in Q4 2017.
  • 71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Wellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.